Thank you for the recap. I’ve been traveling and haven’t been able to watch the presentation. What exactly is meant by 3CL Pharma will be “spun off”? Can you explain that a little more? Thanks in advance

Very possible… it’s also quite possible VERU gets smacked down by the FDA as no other trial showed a 45% mortality in placebo group… This is unheard of

https://www.benzinga.com/general/biotech/22/04/26588305/new-study-reportedly-calls-into-question-mercks-ivermectin-covid-off-label-use-and-may-bolster-3c

https://investor.todosmedical.com/news-events/press-releases/detail/187/todos-medical-applauds-white-house-initiative-on-long-covid

New tweet from CEO

Making available limited supply of Tollovid Daily today. We are saving remaining batch for research to see if as useful as Max in LC which overtook prevention as main daily use. Working on figuring right Daily dosing, if any, for LC and prevention given new variant’s load.

— Gerald Commissiong (@G_Commish) April 5, 2022

https://www.stocktitan.net/news/TOMDF/todos-medical-announces-positive-3cl-protease-inhibition-in-vitro-8nkbkd9edck3.html

https://stocktwits.com/masterrez/message/449504802

https://www.proactiveinvestors.com/companies/news/978603

12.2 million in revenue vs a market cap of 18 million is not proportional… should go up

“During the years ended December 31, 2021 and 2020 we have generated revenues of $12,229,280 and $5,207,142, respectively, by the Company and through our U.S. subsidiaries, Corona Diagnostics, LLC and Provista Diagnostics, Inc.”

https://www.sec.gov/ix?doc=/Archives/edgar/data/1645260/000149315222008594/form10-k.htm

I like this spot for a buy in…. What’s the next catalyst? Earnings report or something else? Thanks in advance

Can anyone tell me when the phase 2 trial is supposed to wrap up and data announced? Thank you in advance

http://ri.biomm.com/default_download.asp?NArquivo=(Biomm)%20Fato%20Relevante%20-%20Aprovac%E3o%20In%EDcio%20dos%20Estudos%20Cl%EDnicos%20Leronlimabe%20-%202%BA%20estudo_V4.pdf&arquivo=1E930690-6952-4B25-8028-AF0F40539087

Actually if you listen to the audio from the other day of his mother (an MD) and his doctors, they said he was given remdesivir and the other drugs and continued to get worse. They discontinued those treatments as the patient did not improve with them. Leronlimab was then given in combo with large doses of vitamins and the patient improved within 3 days…

Nash trial updated today with a completion date of 10/22/21

https://clinicaltrials.gov/ct2/show/NCT04521114

Fake news! This is an emerging growth seminar

Another nice publication

https://www.onclive.com/view/lenrolimab-plus-chemo-demonstrates-substantial-survival-benefit-in-metastatic-tnbc

Another reputable publishing

https://www.targetedonc.com/view/leronlimab-decreases-circulating-tumors-cells-and-extends-survival-in-mtnbc

https://www.cancernetwork.com/view/leronlimab-provides-a-significant-survival-benefit-in-metastatic-triple-negative-breast-cancer

Once again…. Leronlimab was given on day 1 and day 7…. Wearing off by day 14. That is why on day 14 there was an 82% reduction in death…. That being said of course there was no effect of Leronlimab after day 14, the drug was stopped on day 7!

Brazil will have a 3rd and 4th dose

It didn’t kill more… it wasn’t given. The effects were done by day 14.

We will soon have those answers with a 3rd and 4th dose In Brazil

Well Duh!! Leronlimab was only given on days 1 and day 7! It stopped working by day 14! Days 14-28 were virtually all placebo!

At day 14, there was an 82% reduction in death.

The facts are clear…. More Leronlimab was needed

3rd and 4th doses in the Brazil trials will change the everything

August presentation

https://d1io3yog0oux5.cloudfront.net/_a651bfcd20b4439ef4748bd8f7906851/cytodyn/db/193/3263/pdf/CytoDyn+-+Investor+Presentation_Updated+August-2021.pdf

https://translate.googleusercontent.com/translate_p?hl=en&prev=search&sl=pt&u=https://diariodocomercio.com.br/economia/biomm-triplica-a-receita-no-2o-trimestre/&depth=1&rurl=translate.google.com&nv=1&sp=nmt4&pto=aue,ajax,boq&usg=ALkJrhgAAAAAYR3KA2hmuSo4XuSL_4rakbeZ4DrapcUY

HIV & Leronlimab

https://inf.news/en/science/f363aa741e84082bf3034d27d455dd8f.html

Take a look at the biography of the guy running our Brazil trial… pretty strong!

https://academicmedicaleducation.com/otavio-berwanger-md-phd

https://seekingalpha.com/amp/news/3723627-cytodyn-gets-brazil-regulatory-clearance-for-late-stage-covid-19-trial

Who gives a rats ass if Arian is gone? Lawyers are a dime a dozen. She had zero to with anything that moves this drug fwd. As evidenced yesterday, CYDY is not lacking in the legal dept!

Jerry when I posted I did not realize the article was 2014. I’ve asked mods to delete my post but haven’t

https://valor-globo-com.translate.goog/empresas/noticia/2021/08/02/anvisa-autoriza-biomm-a-realizar-estudo-de-fase-3-de-medicamento-contra-covid-19.ghtml?_x_tr_sl=pt&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=ajax,nv,sc,elem

The link to Brazil trial approval is on CYDY’s website. It doesn’t work when shared

The picture of approval is all over. Don’t know how to post picture. Sorry

Brazil approved

https://d1io3yog0oux5.cloudfront.net/cytodyn/files/pages/cytodyn/db/256/content/2021-08-02+-+English+Version+final+%28Biomm%29+Fato+Relevante+-+Aprovação+In%C3%ADcio+dos+Estudos+Cl%C3%ADnicos+Leronlimabe+-FINAL+AUG2ND_final.pdf

Brazil trials approved! Biomm sent out a PR

"The Notice Letter does not state that: (i) the Company’s consulting agreement with IncellDx was terminated by Dr. Patterson, (ii) in May 2020, IncellDx made a private offer to be purchased by CYDY, which CYDY rejected because it was not in the best interest of the Company and its stockholders, and (iii) Dr. Patterson attempted to patent certain uses of the Company’s drug candidate, leronlimab, as his own, which was rejected by the U.S. Patent and Trademarks Office. These facts make Dr. Patterson highly conflicted with respect to CYDY and are therefore material, and none of these material facts have been disclosed in the Notice Letter."

Here’s the actual letter

https://newsfilter.io/a/a3e8d4bad27df43b8ec007334589dcc7

350 million for Inceldx…. Lmfao

“The company said there were many errors in the activists' notice letter. For example, Bruce Patterson, one of the group's board nominees, in May proposed that CytoDyn buy IncellDx, Inc where he serves as CEO, but the notice letter failed to disclose the bid or how Patterson might have benefited personally had the deal not been rejected by CytoDyn.”??